inContAlert
PrivateLast Round
Pre Seed
Sep 6, 2023
Total Funding Raised
$2.73M
Company Overview
inContAlert operates in Healthcare & Life Sciences and is based in Bayreuth. Its latest recorded funding round was a Pre Seed round in September 2023.
inContAlert is a medical technology company that develops a wearable sensor system for measuring the filling level of the urinary bladder to assist patients with neurogenic bladder dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inContAlert Comparables
Compare inContAlert with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PIPO srls | 88% | |
| DFree Inc. | 82% | |
| Augment Health, Inc. | 79% |
For institutional investors. Book with your work email.
inContAlert Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 6, 2023 | ||||
| Grant | Sep 30, 2021 | ||||
| Grant | May 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
inContAlert Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bayern Kapital | Pre Seed |
| CARMA FUND | Pre Seed |
| High-Tech Gründerfonds | Pre Seed |
| NIALLS FOUNDATION | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 54% MoM.
For institutional investors. Book with your work email.
inContAlert Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about inContAlert's valuation, stock price, and market status.
Is inContAlert a public or private company?
inContAlert is a private company.
What is the current stock price of inContAlert?
inContAlert is a private company, so its shares have no public market price. Caplight tracks inContAlert's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is inContAlert worth (valuation)?
Valuation information for inContAlert is not publicly available.
Can I buy inContAlert stock?
inContAlert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was inContAlert's last funding round?
inContAlert's most recent funding round was Pre Seed on September 6, 2023.
Who are the main investors in inContAlert?
Key investors in inContAlert include Bayern Kapital, CARMA FUND, High-Tech Gründerfonds.
Will inContAlert IPO soon?
No public IPO plans have been announced for inContAlert.
How can I track inContAlert secondary market activity?
Caplight tracks bids, offers, and trades in inContAlert's shares on secondary markets.